Free Trial

Eun Yang Analyst Performance

Analyst at Jefferies Financial Group

Eun Yang is a stock analyst at Jefferies Financial Group, covering 36 publicly traded companies across a range of sectors. Over the past year, Eun Yang has issued 1 stock ratings, including and buy recommendations. While full access to Eun Yang's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Eun Yang's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
123 Last 11 Years
Buy Recommendations
73.77% 90 Buy Ratings
Companies Covered
36 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy73.8%90 ratings
Hold23.0%28 ratings
Sell3.3%4 ratings

Out of 122 total stock ratings issued by Eun Yang at Jefferies Financial Group, the majority (73.8%) have been Buy recommendations, followed by 23.0% Hold and 3.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
36 companies

Eun Yang, an analyst at Jefferies Financial Group, currently covers 36 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
31 companies
86.1%
Miscellaneous
3 companies
8.3%
Energy
1 company
2.8%
Aerospace
1 company
2.8%

Eun Yang of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on and Energy companies.

Coverage Industries

IndustryPercentage
PHARMACEUTICAL PREPARATIONS
13 companies
36.1%
MED - BIOMED/GENE
12 companies
33.3%
MED - DRUGS
4 companies
11.1%
Miscellaneous
3 companies
8.3%
MED - GENERIC DRG
1 company
2.8%
SOLAR
1 company
2.8%
AEROSP/DEF EQ
1 company
2.8%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
2.8%

Eun Yang's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/2/2025Boost Price Target$411.21$564.00Buy